Bruker Corporation · NASDAQ:BRKR
Bruker — Bank of America & Merrill Lynch 2009 Health Care Conference
14 slides from Bruker's conference presentation, May 12, 2009
Slide 1: Bruker Corporation (BRKR) Overview
Bruker Corporation (BRKR) Overview Bank of America & Merrill Lynch 2009 Health Care Conference May 12, 2009 Frank Laukien, President & CEO William Knight, CFO Stacey Desrochers, Treasurer & IR Director
Slide 2: Safe Harbor Statement
Bruker Corporation Safe Harbor Statement Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are
Slide 3: Breakdown of 2008 Revenue: Bruker Can Weather a Severe Recession
Breakdown of 2008 Revenue Bruker Can Weather a Severe Recession Revenue by Customers Revenue by Geography 2008 Annual Revenue: $1.1 Billion Stimulus funding and supplementary budgets can cushion recession and may even provide upside for Bruker Revenue by Product System Sales 77% Service, Consumables
Slide 4: New Opportunities: Japan NPA Order for 51 Mass Spectrometers
New Opportunities: Japan National Police Agency (NPA) Order for 51 Mass Spectrometers for Forensics Capturing Supplementary Budgets In late 2008, the Japanese National Police Agency (NPA) signed a $12M contract (from supplementary budget) for 51 Bruker micrOTOF II ESI-TOF mass spectrometers for: Exa
Slide 5: Key Financials: Growth, Margins & Cash Flow
Key Financials Growth, Margins & Cash Flow BRKR 2008 Financials Revenue $1.1B ($1.03B in 2007) 7% GAAP growth (3% FX-adjusted) Adj. EBITDA $170M ($196M in 2007) Non-GAAP EPS $0.47 ($0.66 in 2007) Operating Cash Flow $107M ($108M in 2007) 12/31/08: Net Debt $56.1M Q1-09 Financial Results GAAP: 3.3% r
Slide 6: Bruker BioSpin's Global Leadership in NMR Spectroscopy
Quantum Jumps in Performance Bruker BioSpin’s Global Technology and Market Leadership in NMR Spectroscopy November 2008: Saudi KAUST order of 10 NMR systems for ~$20M (revenue not recognized yet) 2 New Unique Ultra-High Field NMR Magnet Introductions at ENC 2009 world’s highest field, actively shiel
Slide 7: World's First Solid State DNP-NMR Spectrometer
Quantum Jumps in Performance World’s First Solid State DNP-NMR Spectrometer with >50x Signal Enhancement Factor! World’s first Commercial solid state Dynamic Nuclear Polarization (DNP)-NMR spectrometer, co-developed with MIT Polarization enhancement yields factor 50-150x gain in sensitivity for Soli
Slide 8: Revolution in Mass Spectrometry: maXis UHR-TOF
Quantum Jumps in Performance Revolution in Mass Spectrometry maXis™ UHR-TOF launched at ASMS 2008 Bruker has ‘rewritten the book’ with UHR-TOF Ultra-high resolution 40-60k Broad mass range and high mass Mass accuracy in MS & MS/MS <1ppm High speed at 20 full spectra/sec Isotopic fidelity for molecul
Slide 9: Revolution in Mass Spectrometry Continues
Quantum Jumps in Performance Revolution in Mass Spectrometry Continues New MALDI, FTMS and Ion Trap Products NEW – April 2009 ultrafleXtreme MALDI TOF/TOF Unmatched High Performance New ultrafleXtreme™ is Fastest and Most Flexible MALDI-TOF/TOF 1 kHz proprietary smartbeam™-II laser True 1 kHz in TOF
Slide 10: X-ray Revolution: High-Performance Systems for Broader Markets
Quantum Jumps in Performance X-ray Revolution: Unique, High-Performance Systems for Broader Markets and New Users 2008 PITTCON Editor’s Gold and R&D 100 Award Winner SMART X2S World’s First Fully Automated Molecular Structure Machine NEW-2009 S8 LION Simultaneous WD-XRF Spectrometer for Quality and
Slide 11: New Opportunities: Bruker Advanced Supercon Business
New Opportunities: Bruker Advanced Supercon Business Superconductors and Supercon Devices March 2009: Bruker and Nexans Successfully Complete EU HTS Superconducting Cable Bruker is developing more efficient, flexible and reliable energy technologies Euro 5.2M HTS ‘Super 3C’ cable project met targete
Slide 12: New Opportunities: MALDI-TOF MS Based Edmass Solution
New Opportunities: MALDI-TOF MS Based Edmass™ Solution Next-Gen Protein Sequencing! MALDI In-Source-Decay Mass Spectrometry A single Edmass™ spectrum can provide for sequence calls of >80 a.a. residues in seconds Both N- and C-terminals can be assigned using T3-sequencing on Bruker MALDI TOF/TOF Unm
Slide 13: New Opportunities: Bruker MALDI Molecular Imager
New Opportunities: Bruker MALDI Molecular Imager™ MALDI Tissue Imaging and Molecular Histology Complete MALDI Molecular Imaging Solution: For proteins, peptides, lipids based on MALDI-TOF New: FTMS Imaging of drugs and metabolites in tissues at therapeutic dosing levels ImagePrep™ Sampling Robot MAL
Slide 14: www.bruker.com
www.bruker.com Important: May 11 BRKR press release on amaZon™ next-gen ion trap, and May 12 BRKR press release on solariX™ next-gen FTMS. At ASMS 2009, Bruker will show most advanced, brand-new MALDI-TOF/TOF, Ion Trap and FTMS high-performance systems.
Bruker — Bank of America & Merrill Lynch 2009 Health Care Conference on 6ix